Thalassemia Drugs Market Analysis With opportunity segments
Thalassemia Drugs Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
LONDON, GREATER LONDON, UK, July 3, 2024 /EINPresswire.com/ — The global thalassemia drugs market is projected to grow from $2.07 billion in 2023 to $2.3 billion in 2024, at a compound annual growth rate (CAGR) of 11.4%. Despite the challenges faced, the market is anticipated to reach $3.4 billion by 2028, driven by the increasing prevalence of thalassemia, genetic predispositions, and advancements in healthcare infrastructure.
Increasing Healthcare Expenditure Drives Market Growth
The increasing healthcare expenditure is a significant factor contributing to the growth of the thalassemia drug market. Organized provision of medical services, including specialized treatment centers equipped to handle thalassemia cases, supports the administration of thalassemia drugs and related therapies. For instance, India’s public expenditure on healthcare stood at 2.1% of GDP in 2021-22. Moreover, global healthcare benefit costs increased from 8.2% in 2021 to 8.8% in 2022 and are expected to grow again in 2023 to a high global average of 10%. This increased expenditure will drive the growth of the thalassemia drug market.
Explore comprehensive insights into the global thalassemia drugs market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=12213&type=smp
Key Players and Market Trends
Major companies operating in the thalassemia drugs market include Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., Fresenius Kabi AG, Bristol Myers Squibb Co., and GlaxoSmithKline PLC. These companies are focusing on product development and production of thalassemia drugs, such as beta-thalassemia drugs, to sustain their market position. For instance, in August 2022, Bluebird Bio Inc. announced a groundbreaking $2.8 million beta-thalassemia drug, highlighting the industry’s drive for innovation.
Segments:
• Type: Alpha Thalassemia Drugs, Beta Thalassemia Drugs
• Treatment Type: Iron Chelation Therapy, Other Treatments
• Distribution Channel: Hospital Pharmacies, Online Providers, Drug Stores And Retail Pharmacies
Geographical Insights: Asia-Pacific Leading the Market
Asia-Pacific led the thalassemia drugs market in 2023 and is expected to be the fastest-growing region. The comprehensive report provides detailed insights into regional dynamics, market trends, and growth opportunities.
Order your report now for swift delivery: https://www.thebusinessresearchcompany.com/report/thalassemia-drugs-global-market-report
Thalassemia Drugs Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Thalassemia Drugs Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on thalassemia drugs market size, thalassemia drugs market drivers and trends, thalassemia drugs market major players, competitors’ revenues, market positioning, and market growth across geographies. The thalassemia drugs market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Anti-Hypertensive Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report
Drugs For Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Acne Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report
About The Business Research Company?
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
